Don Bradman,
"It also doesnt say much for Australian media's knowledge/interest in the bio-tech community. Maybe PXS have to waste taxpayer money on a synchotron to get noticed. Still Cochlear and CSL used to be well under $10 too! "
I spoke with PXS management a couple of years ago when they were doing the listing on the US. The reason for that listing was partly to do with the fact that US analysts understand these types of stocks better than the Aussies. This validates your post, they don't know how to cover these stocks.
PXS is to a certain extent a "bottom drawer" stock...the recent announcement has reduced the risks. I have no doubt that this will be fast tracked and given the FDA approval in due course.
Good luck to all that hold.
- Forums
- ASX - By Stock
- SNT
- first broker upgrade: 5.10
first broker upgrade: 5.10, page-11
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
3.1¢ |
Change
0.001(3.33%) |
Mkt cap ! $40.00M |
Open | High | Low | Value | Volume |
3.0¢ | 3.1¢ | 3.0¢ | $16.17K | 538.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 366566 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.1¢ | 422617 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 366566 | 0.030 |
10 | 2265822 | 0.029 |
5 | 1574111 | 0.028 |
1 | 100000 | 0.026 |
2 | 446248 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.031 | 377163 | 3 |
0.032 | 50000 | 1 |
0.033 | 665000 | 1 |
0.034 | 160000 | 1 |
0.035 | 400000 | 1 |
Last trade - 15.57pm 06/09/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |